Status:
RECRUITING
Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis
Lead Sponsor:
University of Salerno
Conditions:
Low Flow, Low Gradient Aortic Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aorti...
Detailed Description
LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aorti...
Eligibility Criteria
Inclusion
- LFLG-AS diagnosis according to current European Society of Cardiology guidelines
- Age 18 years or older
- Written informed consent
Exclusion
- LFLG-AS pseudo-severe or non-confirmed severe aortic stenosis
- LFLG-AS referred for medical treatment or undergoing surgery
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2037
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06589063
Start Date
March 1 2024
End Date
December 31 2037
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Salerno
Salerno, Italy, Italy, 84131